Abstract

Stability of Vancomycin in SyrSpend SF

Author(s): Whaley Paul A, Voudrie Mark A II

Issue: Mar/Apr 2012 - Volume 16, Number 2

Page(s): 167-169

Download in electronic PDF format for $75
  • Stability of Vancomycin in SyrSpend SF Page 1
  • Stability of Vancomycin in SyrSpend SF Page 2
  • Stability of Vancomycin in SyrSpend SF Page 3

Note: Electronic version includes errata or revisions.

Abstract

Vancomycin is administered orally for the treatment of pseudomembranous colitis induced by Clostridium difficile. Vancomycin is marketed for this purpose by ViroPharma as VANCOCIN in 125-mg and 250-mg capsules. The need for other dose form options for those patients who cannot take capsules has led compounding pharmacies to seek other alternatives, namely oral solutions and suspensions. Additionally, some patients are unable to use suspending agents containing alcohol or sorbitol. The objective of this study was to determine the stability of vancomycin in SyrSpend SF, a suspending agent containing neither sorbitol nor alcohol. The studied sample was compounded into a 50-mg/mL suspension and stored in a low-actinic plastic bottle at temperatures between 2oC and 8oC. Six samples were assayed at each time point out to 90 days by a stability-indicating high-performance liquid chromatography method. The method was validated for its specificity through forced-degradation studies. The sample remained within 90% to 110% of the initial concentration throughout the course of the study. Based on data collected, the shelf life of this product is at least 90 days when refrigerated and protected from light. Based on the final potency data at day 90, the beyond-use date may be longer, but 90 days was the limit of this study.

Related Keywords

  • vancomycin
  • antibiotic
  • pseudomembranous colitis
  • Clostridium difficile
  • suspension
  • stabiltiy

Related Categories

  • EXCIPIENTS
  • PEER-REVIEWED
  • STABILITIES, COMPATIBILITIES
  • INFECTIOUS DISEASE
  • STORAGE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2012
Pg. 167-169
Stability of Vancomycin in SyrSpend SF
Author(s): Whaley Paul A, Voudrie Mark A II
Jul/Aug 2010
Pg. 346-349
Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin
Author(s): Baker Daniel S, Waldrop Bruce, Arnold John
Mar/Apr 1997
Pg. 123-124
Stability of Vancomycin HCl in MEDICATION CASSETTE Reservoirs
Author(s): Allen Loyd V Jr, Stiles M Lou
Jan/Feb 2002
Pg. 55-57
New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems
Author(s): Kastango Eric S, Hadaway Lynn
Jul/Aug 2022
Pg. 330-335
Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes
Author(s): Bartoll Aaron Puplà, Bellés Medall Maria Dolores, Peñarrocha Josep Edo, Escrig Laura Solaz, Clemente Ruben Eguren, Azuara Julia Bodega, Piqueres Raul Ferrando
Mar/Apr 2008
Pg. 170-173
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Author(s): Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
Sep/Oct 2008
Pg. 456-459
Testing the Long-Term Stability of Vancomycin Ophthalmic Solution
Author(s): McLellan Christine, Ngo Van, Pasedis Sophia, Dohlman Claes H
Mar/Apr 2016
Pg. 159-163
Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups
Author(s): Kirk Loren, Lewis Paul, Luu Yao, Brown Stacy
Jul/Aug 2016
Pg. 347-350
Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product
Author(s): Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
Nov/Dec 2018
Pg. 516-526
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Jul/Aug 2020
Pg. 327-336
Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4
Author(s): Espana B, Joseph-Tornabène F, Jaquet Cécile, Perrot S, Prouillac C
Sep/Oct 2015
Pg. 420-427
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF
Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul
Sep/Oct 2017
Pg. 417
Vancomycin 50 mg/mL in Oral Syrup Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2013
Pg. 344-346
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry
Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul A
Nov/Dec 2008
Pg. 558-564
Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System
Author(s): Vu Nicole T, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
Sep/Oct 2003
Pg. 354-356
Sterile Vancomycin Pluronic Gel for Implantation in the Chest-Wall Cavity to Treat Resistant Pneumococcus
Author(s): Gray Cary, Shome Sibaji, Muller George
Jan/Feb 2016
Pg. 56
Vancomycin 5% and Amikacin 2% Ophthalmic Solution
Author(s): Allen Loyd V Jr
Jan/Feb 2010
Pg. 82-85
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution)
Author(s): Voudrie Mark A II, Allen D Brett
Nov/Dec 1997
Pg. 418
Vancomycin Gel (Vancomycin Paste, Vanc Paste)
Author(s): Allen Loyd V Jr
Jul/Aug 2012
Pg. 347-349
Stability of Gabapentin in SyrSpend SF
Author(s): Sorenson Bridget, Voudrie Mark A II, Gehrig Dan